Home
TNDM
TNDM News

Latest Tandem Diabetes Care Inc. (TNDM) News on June 1, 2025

Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?

Zacks

2 days ago

Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?

Healthcare Technology Stocks Q1 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

StockStory

3 days ago

Healthcare Technology Stocks Q1 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM)

StockStory

6 days ago

Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM)

Tandem Diabetes and Roche Reach a Patent Settlement

Insider Monkey

7 days ago

Tandem Diabetes and Roche Reach a Patent Settlement

Tandem Diabetes, Roche enter patent settlement agreement

TipRanks

8 days ago

Tandem Diabetes, Roche enter patent settlement agreement

Morningstar Research

10 days ago

Analyst Report: Tandem Diabetes Care, Inc.

Should Tandem Diabetes Stock Stay in Your Portfolio Now?

Zacks

10 days ago

Should Tandem Diabetes Stock Stay in Your Portfolio Now?

Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know

StockStory

11 days ago

Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know

1 Momentum Stock with Impressive Fundamentals and 2 to Turn Down

StockStory

16 days ago

1 Momentum Stock with Impressive Fundamentals and 2 to Turn Down

TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures

StockStory

18 days ago

TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures

Argus Research

19 days ago

TNDM: Raising target price to $24.00

Exploring 3 Undervalued Small Caps With Insider Action Across Regions

Simply Wall St.

20 days ago

Exploring 3 Undervalued Small Caps With Insider Action Across Regions

3 of Wall Street’s Favorite Stocks in Dangerous Territory

StockStory

20 days ago

3 of Wall Street’s Favorite Stocks in Dangerous Territory

Argus Research

a month ago

TNDM: Raising target price to $22.00

Tandem Diabetes Care Announces Upcoming Conference Presentations

Business Wire

a month ago

Tandem Diabetes Care Announces Upcoming Conference Presentations

TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up

Zacks

a month ago

TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up

Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

a month ago

Q1 2025 Tandem Diabetes Care Inc Earnings Call

Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ...

GuruFocus.com

a month ago

Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ...

Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

a month ago

Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars

StockStory

a month ago

Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Zacks

a month ago

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars

StockStory

a month ago

Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars

What to Expect From These 3 MedTech Stocks This Earnings Season?

Zacks

a month ago

What to Expect From These 3 MedTech Stocks This Earnings Season?

Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For

StockStory

a month ago

Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For

Argus Research

a month ago

TNDM: Lowering target price to $17.00

1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar

StockStory

a month ago

1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar

Reasons to Hold TNDM Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Hold TNDM Stock in Your Portfolio for Now

Argus Research

2 months ago

TNDM: Raising target price to $19.00

MT Newswires

2 months ago

RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

StockStory

2 months ago

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

Motley Fool

2 months ago

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

3 Undervalued Small Caps With Recent Insider Activity Across Regions

Simply Wall St.

2 months ago

3 Undervalued Small Caps With Recent Insider Activity Across Regions

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?

Zacks

2 months ago

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?

MT Newswires

2 months ago

Mizuho Initiates Tandem Diabetes Care at Neutral With $20 Price Target

Argus Research

2 months ago

TNDM: Lowering target price to $17.00

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Business Wire

2 months ago

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Morningstar Research

2 months ago

Analyst Report: Tandem Diabetes Care, Inc.

Argus Research

2 months ago

TNDM: Lowering target price to $20.00

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

StockStory

2 months ago

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

Argus Research

2 months ago

TNDM: What does Argus have to say about TNDM?

Tandem announces publication of results from trial of Control-IQ+ AID technology

TipRanks

2 months ago

Tandem announces publication of results from trial of Control-IQ+ AID technology

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MedTech Dive

2 months ago

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes

Business Wire

2 months ago

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes

TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology

Zacks

2 months ago

TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

Business Wire

2 months ago

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

3 Healthcare Stocks Walking a Fine Line

StockStory

2 months ago

3 Healthcare Stocks Walking a Fine Line

Reasons to Hold TNDM Stock in Your Portfolio for Now

Zacks

3 months ago

Reasons to Hold TNDM Stock in Your Portfolio for Now

Argus Research

3 months ago

TNDM: Lowering target price to $16.00

Investing.com

3 months ago

Bernstein downgrades Tandem Diabetes on market share loss concerns

MT Newswires

3 months ago

Bernstein Downgrades Tandem Diabetes Care to Market Perform From Outperform, $35 Price Target

Loss-Making Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected To Breakeven In The Medium-Term

Simply Wall St.

3 months ago

Loss-Making Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected To Breakeven In The Medium-Term

Morningstar Research

3 months ago

Analyst Report: Tandem Diabetes Care, Inc.

Tandem Diabetes Crashes 35% As Light Outlook Rattles Pump-Maker's Shares

Investor's Business Daily

3 months ago

Tandem Diabetes Crashes 35% As Light Outlook Rattles Pump-Maker's Shares

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

Zacks

3 months ago

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

MT Newswires

3 months ago

UBS Adjusts Price Target on Tandem Diabetes Care to $35 From $40, Keeps Neutral Rating

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Tandem Diabetes Care Inc Earnings Call

Tandem Diabetes Care (TNDM) Slid in Q4 Despite Strong Results

Insider Monkey

3 months ago

Tandem Diabetes Care (TNDM) Slid in Q4 Despite Strong Results

MT Newswires

3 months ago

RBC Cuts Price Target on Tandem Diabetes Care to $55 From $65, Keeps Outperform Rating

MT Newswires

3 months ago

Tandem Diabetes Care Q4 Swings to Earnings, Revenue Rises

Tandem Diabetes Care Inc (TNDM) Q4 2024 Earnings Call Highlights: Record Sales Growth and ...

GuruFocus.com

3 months ago

Tandem Diabetes Care Inc (TNDM) Q4 2024 Earnings Call Highlights: Record Sales Growth and ...

Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings

Zacks

3 months ago

Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings

Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue Estimates

Zacks

3 months ago

Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue Estimates

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

Medical Device Network

3 months ago

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

MT Newswires

3 months ago

Tandem Diabetes Care Says FDA Clears Insulin Delivery Technology for Type 2 Diabetes

Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

3 months ago

Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Business Wire

3 months ago

Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

StockStory

3 months ago

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

Zacks

3 months ago

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

Argus Research

3 months ago

TNDM: Lowering target price to $26.00

Tandem Diabetes Care Announces Upcoming Conference Presentations

Business Wire

4 months ago

Tandem Diabetes Care Announces Upcoming Conference Presentations

Argus Research

4 months ago

TNDM: What does Argus have to say about TNDM?

Wealth management platform Prosper secures $4.9m

Private Banker International

4 months ago

Wealth management platform Prosper secures $4.9m

Argus Research

4 months ago

TNDM: Raising target price to $29.00

Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?

Zacks

4 months ago

Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?

Argus Research

4 months ago

TNDM: Lowering target price to $28.00

Reasons to Retain TNDM Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain TNDM Stock in Your Portfolio for Now

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Business Wire

5 months ago

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Argus Research

5 months ago

TNDM: Lowering target price to $29.00

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

Zacks

5 months ago

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

MT Newswires

5 months ago

Bernstein Adjusts Price Target on Tandem Diabetes Care to $44 From $42, Maintains Outperform Rating

MT Newswires

5 months ago

Tandem Diabetes Care Launches Collaboration With University of Virginia to Develop Insulin Delivery Systems

Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems

Business Wire

5 months ago

Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems

Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock?

Zacks

5 months ago

Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock?

Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Trading At A 46% Discount?

Simply Wall St.

5 months ago

Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Trading At A 46% Discount?

Argus Research

5 months ago

TNDM: Raising target price to $29.00

Argus Research

5 months ago

TNDM: What does Argus have to say about TNDM?

TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada

Zacks

6 months ago

TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada

Argus Research

6 months ago

TNDM: What does Argus have to say about TNDM?

Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada

Business Wire

6 months ago

Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada

Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?

Zacks

6 months ago

Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?

Reasons to Retain TNDM Stock in Your Portfolio for Now

Zacks

6 months ago

Reasons to Retain TNDM Stock in Your Portfolio for Now

Argus Research

6 months ago

TNDM: Raising target price to $27.00

Argus Research

6 months ago

TNDM: Raising target price to $24.00

Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now

Insider Monkey

6 months ago

Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now

Tandem Diabetes Care Announces Upcoming Conference Presentations

Business Wire

6 months ago

Tandem Diabetes Care Announces Upcoming Conference Presentations

Argus Research

7 months ago

TNDM: Lowering target price to $25.00

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket

Zacks

7 months ago

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket

Tandem Diabetes price target lowered to $37 from $39 at Baird

TipRanks

7 months ago

Tandem Diabetes price target lowered to $37 from $39 at Baird

Share on Social Networks: